M1 macrophage-derived exosomes inhibit cardiomyocyte proliferation through delivering miR-155

Xiaoqing He1, Shan Liu1, Zhanyu Zhang1

  • 1Department of Cardiology, Guangdong Key Laboratory of Vascular Diseases, The Second Affiliated Hospital, Guangzhou Institute of Cardiovascular Disease, Guangzhou Medical University, Guangzhou, 510260, People's Republic of China.

PubMed
Abstract

Insights

M1 macrophage-derived exosomes (M1-Exos) deliver miR-155 to inhibit cardiomyocyte proliferation by targeting the IL-6 receptor and JAK/STAT3 pathway, impacting cardiac repair after myocardial infarction.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Immunology

Background:

  • M1 macrophages are implicated in cardiac injury following myocardial infarction (MI).
  • Exosomes play a significant role in post-MI pathophysiological regulation.
  • The specific function of M1 macrophage-derived exosomes (M1-Exos) in myocardial regeneration is not well understood.

Purpose of the Study:

  • To investigate the impact of M1-Exos on cardiomyocyte regeneration.
  • To elucidate the underlying molecular mechanisms of M1-Exos in cardiac repair.

Main Methods:

  • M1 macrophages were differentiated and M1-Exos isolated.
  • Cardiomyocyte proliferation was assessed in vitro and in vivo.
  • miR-155 levels, exosome transfer, and the IL-6R/JAK/STAT3 pathway were analyzed.

Main Results:

  • M1-Exos suppressed cardiomyocyte proliferation.
  • miR-155 was transferred from M1-Exos to cardiomyocytes, inhibiting proliferation.
  • miR-155 targeted IL-6 receptor (IL-6R) and suppressed the JAK/STAT3 signaling pathway.

Conclusions:

  • M1-Exos inhibit cardiomyocyte proliferation via miR-155 delivery, targeting the IL-6R/JAK/STAT3 pathway.
  • This study offers novel insights into macrophage-mediated myocardial regeneration and potential therapeutic strategies for cardiac repair.